MT DPHHS Diabetes Program Presents Montana Diabetes Professional Conference

MT DPHHS Diabetes Program PresentsMontana Diabetes Professional Conference

Conference Speakers

2021 Diabetes Speakers (in order of session appearance)

*Visit the Agenda page for session times, any handouts, and additional disclosure information. The webinar recording will also be posted on the agenda page (without CEs) on November 2nd. 

2021 Printable Agenda


The Natural History of Cardiometabolic Disease

Neil Kaminsky, MD

Neil Kaminsky

When caring for people with Type 2 Diabetes, providers often focus solely on blood sugar control. However, cardiovascular disease is the leading cause of death in individuals with T2DM. Along the continuum of what is now known as cardiometabolic disease, damage from high blood sugar is confounded by hyperlipidemia and hypertension.  This talk will present the natural history of cardiometabolic disease.

Dr. Neil Kaminsky, MD is an Endocrinology, Diabetes & Metabolism Specialist in Albuquerque, NM, and has over 59 years of experience in the medical field.  He graduated from Washington University St Louis medical school and is currently an Associate Clinic Professor at the University of New Mexico.

Diabetes and Covid-19: Emerging evidence regarding risk, prognosis, management, practical considerations and impact of the viral pandemic
Alana Barber, MSN, FNP-BC, BC-ADM

Alana BarberThis conference session will focus on Covid-19 and its impact on patients and health care providers within the diabetes community. Information within the session will include diabetes risk factors in association with Covid-19; complications of Covid-19 commonly seen within the diabetes community; diabetes treatment and management during Covid-19 infection; practical considerations; newly emerging data, and case studies.

Alana Barber, MSN, FNP-BC, BC-ADM has been a Registered Nurse since 2004 and a Board Certified Family Nurse Practitioner since 2012. She has is currently employed as a nurse practitioner at the St. Vincent Healthcare Diabetes Center in Billings, MT where she helps manage gestational and type 1 and type 2 diabetes.

Understanding and Addressing Problematic Medication Adherence in Diabetes Care
William Polonsky, PhD, CDCES

William PolonskyIn this session, we will take a close look at the real-world barriers and challenges that patients and their health care providers face regarding medication adherence, and we will then put forward practical strategies for assessing and addressing these issues. As an overarching goal, we hope to highlight the need for a more collaborative relationship between patients and health care providers that is respectful of the role that patients play in their own treatment decisions.

Dr. William H. Polonsky, Ph.D., CDCES is President and Co-Founder of the Behavioral Diabetes Institute, the world's first organization wholly dedicated to studying and addressing the unmet psychological needs of people with diabetes. He is also an Associate Clinical Professor in Medicine at the University of California, San Diego. Dr. Polonsky received his Ph.D. in clinical psychology from Yale University and has served as Senior Psychologist at the Joslin Diabetes Center in Boston, a faculty member at Harvard Medical School, and Chairman of the National Certification Board for Diabetes Educators. A licensed clinical psychologist and certified diabetes care and educational specialist, he received the American Diabetes Association’s 2020 Outstanding Educator in Diabetes Award and the American Diabetes Association’s 2014 Richard R. Rubin Award for distinguished contributions to behavioral medicine and psychology.  

Management of Hypoglycemia in Diabetic Patients
Michael J. Clare-Salzler, M.D.

Michael J. Clare-Salzler, M.D. The risk of hypoglycemia in patients with diabetes can be a barrier to better control of blood glucose. In addition, identifying those patients at significant risk for clinically significant hypoglycemia is an important approach to keep patients safe. Finally, understanding the physiologic mechanisms contributing to hypoglycemia as well as the effects of hypoglycemia on downstream glucose levels can help to avoid this complication and improve control. The objectives of this talk are;
• Develop an approach to manage and prevent hypoglycemia in Type 1 (T1D) and Type 2 (T2D) diabetes
• Develop an understanding of contributing factors to hypoglycemia
• Understand the physiology of normal and abnormal responses to low glucose

Michael J. Clare-Salzler, MD, is a professor of medicine and endocrinology who received his medical degree and internal medicine training from the State University of New York at Buffalo. He began his clinical endocrinology and immunology research career at the University of California in Los Angeles, where he studied the immunopathogenesis of type 1 diabetes and later at the University of Florida for 28 years. Dr. Clare-Salzler’s practice in endocrinology spanned the breadth of endocrine diseases and diabetes with particular expertise in the areas of molecular pathogenesis, diagnosis, treatment and management of diabetes complications.

New Technologies to Improve Diabetes Care
Diana Isaacs, PharmD, BCPS, BC-ADM, CDE

Diana IsaacsAdvances in technology offer new device choices such as insulin delivery devices, CGM, connected pens, and automated insulin delivery systems. This presentation will provide an update of what healthcare professionals need to know about these new technologies, who will benefit most, and what’s in the pipeline.

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP is the Remote Monitoring and CGM Program Coordinator and Endocrinology Clinical Pharmacy Specialist at the Cleveland Clinic Diabetes Center.  Dr. Isaacs earned her Bachelor’s Degree in Chemistry from the University of Illinois at Chicago, Doctor of Pharmacy Degree from Southern Illinois University Edwardsville, and completed residency at the Philadelphia VA Medical Center.  Dr. Isaacs holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management.   In 2020, she was awarded Fellow status in the Association of Diabetes Care and Education Specialists (ADCES) and American College of Clinical Pharmacy (ACCP).  She is the Communications Director for the American Diabetes Association (ADA) Pregnancy and Reproductive Health Interest Group and serves on the 2020-2021 ADA Professional Practice Committee, the committee that updates the ADA Standards of Care. She is also the president of the Ohio Association of Diabetes Care and Education Specialists (ADCES).  She presents on diabetes-related topics nationally and internationally.  Dr. Isaacs was awarded the Ohio Pharmacists Association Under 40 Award in 2019 and ADCES Diabetes Care and Education Specialist of the Year in 2020.